BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26329876)

  • 1. Expression of RAP1B is associated with poor prognosis and promotes an aggressive phenotype in gastric cancer.
    Yang Y; Li M; Yan Y; Zhang J; Sun K; Qu JK; Wang JS; Duan XY
    Oncol Rep; 2015 Nov; 34(5):2385-94. PubMed ID: 26329876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal phenotype of Nrf2 is associated with poor prognosis through hypoxic/VEGF-A-Rap1b/VEGFR2 pathway in gastric cancer.
    Yang Y; Wang X; Zhang J; Gu H; Zhang S; Sun H; Liu J; Fan R
    Aging (Albany NY); 2022 Apr; 14(7):3293-3312. PubMed ID: 35417854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth.
    Li M; Xiao D; Zhang J; Qu H; Yang Y; Yan Y; Liu X; Wang J; Liu L; Wang J; Duan X
    Oncol Rep; 2016 Dec; 36(6):3479-3487. PubMed ID: 27805252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
    Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
    Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
    Xia T; Cheng H; Zhu Y
    Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expressions of Jumonji domain containing protein 2C and hypoxia-inducible factor-1α in gastric carcinoma and their clinical significance].
    Xu Y; Yao HB; Jin Y; Ma YY; Wang HJ; Shao QS
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3375-8. PubMed ID: 24418035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
    Zhang C; Tian W; Meng L; Qu L; Shou C
    J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and clinical significance of hypoxia-inducible factor-1alpha in gastric cancer].
    Han B; Xu RH; Shi YX; Li YH; Luo HY; Wang F; Hou JH; Cai MY; Jiang WQ
    Ai Zheng; 2006 Nov; 25(11):1439-42. PubMed ID: 17094917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired mitophagy activates mtROS/HIF-1α interplay and increases cancer aggressiveness in gastric cancer cells under hypoxia.
    Shida M; Kitajima Y; Nakamura J; Yanagihara K; Baba K; Wakiyama K; Noshiro H
    Int J Oncol; 2016 Apr; 48(4):1379-90. PubMed ID: 26820502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
    Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
    Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer.
    Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y
    Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.
    Oh YS; Kim HY; Song IC; Yun HJ; Jo DY; Kim S; Lee HJ
    Oncol Rep; 2012 Dec; 28(6):2239-46. PubMed ID: 23023480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis.
    Sun W; Shen ZY; Zhang H; Fan YZ; Zhang WZ; Zhang JT; Lu XS; Ye C
    Oncol Rep; 2012 Jun; 27(6):1990-2002. PubMed ID: 22470047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of SIRT3 is conversely correlated with the progression and prognosis of human gastric cancer.
    Yang B; Fu X; Shao L; Ding Y; Zeng D
    Biochem Biophys Res Commun; 2014 Jan; 443(1):156-60. PubMed ID: 24287180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
    Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
    Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
    Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
    PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas.
    Griffiths EA; Pritchard SA; Valentine HR; Whitchelo N; Bishop PW; Ebert MP; Price PM; Welch IM; West CM
    Br J Cancer; 2007 Jan; 96(1):95-103. PubMed ID: 17179985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.